Status
Conditions
Treatments
About
This study evaluates the pharmacokinetic profile of levetiracetam in critically ill patients who have suffered a subarachnoid hemorrhage. The patients will be evaluated for development of augmented renal clearance and the effects and duration of effects this may have on levetiracetam clearance.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
15 participants in 1 patient group
Loading...
Central trial contact
Edward T Van matre, PharmD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal